Abstract:Chenhao Xing, 1 Yamin Lu, 2 Guangxia Liu, 2 Fang Chen, 2 Zhan Hou, 2 Yiwen Zhang 2 1 Graduate School of Hebei North University, Hebei North University, Zhangjiakou, Hebei, People's Republic of China; 2 Department of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China Correspondence: Yamin Lu, Department of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, 050051, People's Republic of China, Tel +86 15833956939, Email Objective: The purpose of the study was to investigate the expression levels and correlation of inflammatory factors such as miR-377-3p and TGF-β in patients with diabetic kidney disease (DKD), and to investigate the regulatory mechanism of transfection of miR-377-3p on the inflammatory response of HK-2 cell induced by high glucose. Methods: According to UACR, patients were divided into normal albuminuria group (Con, n = 29), microalbuminuria group (Micro, n = 31) and macroalbuminuria group (Macro, n = 30), analyzed the correlation and influencing factors between DKD and inflammatory factor. HK-2 cells were randomly divided into four groups: normal control group (NC), high glucose group (HG), miR-377-3p overexpression group (MIN), and miR-377-3p inhibition group (IN). After transfection of miR-377-3p mimics and inhibitors, the contents of TGF-β, IL-6 and IL-18 were detected by RT-PCR and Western blot. Results: The levels of miR-377-3p, TGF-β, IL-6 and IL-18 in both Micro group and Macro group were significantly higher than those in Con group (P < 0.05); Pearson correlation analysis showed that miR-377-3p was positively correlated with UACR, TG, TGF-β, IL-6 and IL-18, and negatively correlated with GFR (P < 0.05). Cell experiment: RT-PCR and Western blot results showed that miR-377-3p, TGF-β, IL-6 and IL-18 in HG group were significantly higher than those in NC group (P < 0.05). After transfection with miR-377-3p inhibitor, the levels of miR-377-3p, TGF-β, IL-6 and IL-18 in IN group were significantly decreased compared with HG group and MIN group. Conclusion: miR-377-3p expression was elevated both in serum of DKD patients and in HK-2 cells with high glucose induced injury, overexpression of miR-377-3p exacerbates the damage to HK-2 cells and promotes the progression of DKD. Silencing miR-377-3p can potentially regulate the levels of inflammatory factors in HK-2 cells by targeting downregulation of TGF-β expression, thereby mitigating the damage to HK-2 cells and delaying the development of diabetic kidney disease. Keywords: miR-377-3p, transforming growth factor beta, interleukin 6, interleukin 18, renal tubular epithelial cells In recent years, with the improvement of residents' living standards and the change of lifestyle, the incidence of diabetes has increased year by year. As a common complication of diabetes, the incidence of diabetic kidney disease (DKD) also increases with the increase of diabetic patients. 1 Renal tubule injury is considered to be the main cause of the pathogenesis of DKD. 2 Sustained stimulation of high glucose causes damage to renal tubular epithelial cells, leading to the secretion of several inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and vascular cell adhesion molecule-1 (VCAM-1), which promote the inflammatory response. Activate TGF-β and other molecular pathways, 3,4 thereby triggering interstitial inflammation and fibrosis, and mediating the occurrence and development of diabetic kidney disease. 5 MicroRNAs (miRNAs) are important regulators of gene expression in many diseases and can affect many cellular processes, including cell proliferation, differentiation, and apoptosis. 2 It has been reported that miRNA-615-3p is involved in the inflammatory response related to osteoarthritis by increasing the expression of IL-1β, IL-6, interleukin-α and other inflammatory cytokines. 6 miR-10b-5p is one of the earliest miRNAs found to be abnormal in human cancer, and it is involved in inflammation control and inflammation-related diseases by regulating T cells. 7 miR-377 is a new pro-inflammatory factor that can regulate cellular inflammatory response and insulin resistance. Studies have reported that miR-377-3p is closely related to the pathogenesis of DKD. 8 Wang et al believed that miR-377 could increase the expression of matrix proteins and fibronectin, leading to renal tubulointerstitial inflammation and renal fibrosis. 9 TGF-β signaling pathway is the key to the occurrence of diabetic kidney disease and renal tubulointerstitial fibrosis. There may be a regulatory correlation betwee -Abstract Truncated-

MiR-26b Regulates High Glucose-induced Mesangial Cell Hypertrophy Via Targeting GSK3β

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

MicroRNA-26a Regulates Insulin Sensitivity and Metabolism of Glucose and Lipids.

MicroRNA-26a: An Emerging Regulator of Renal Biology and Disease.

MicroRNA-29b Inhibits Diabetic Nephropathy in Db/db Mice.

Upregulation of MiR-126 Delays the Senescence of Human Glomerular Mesangial Cells Induced by High Glucose Via Telomere-p53-p21-Rb Signaling Pathway.

MiR‐17‐5p downregulation alleviates apoptosis and fibrosis in high glucose‐induced human mesangial cells through inactivation of Wnt/β‐catenin signaling by targeting KIF23

Antecedents of Rural Adolescent Alcohol Use: A Risk Factor Approach

miR-372-3p is a potential diagnostic factor for diabetic nephropathy and modulates high glucose-induced glomerular endothelial cell dysfunction via targeting fibroblast growth factor-16

MicroRNAs Involved in the Mitogen-Activated Protein Kinase Cascades Pathway During Glucose-Induced Cardiomyocyte Hypertrophy

MiR-124-3p Suppresses the Dysfunction of High Glucose-Stimulated Endothelial Cells by Targeting G3BP2

LncRNA NEAT1 Promotes High Glucose-Induced Mesangial Cell Hypertrophy by Targeting miR-222-3p/CDKN1B Axis

A novel lncRNA TCONS_00071187 upregulated by activated GSK3β promotes high glucose-induced mesangial cell proliferation in the diabetic nephropathy

MicroRNA‐26a alleviates tubulointerstitial fibrosis in diabetic kidney disease by targeting PAR4

1476-PUB: The Stimulation of High Glucose Can Downregulate Expression of miR-223-3p in HUVECs, Which May Undergo Endothelial–Myofibroblast Transition

Limits for Recombination in a Low Energy Loss Organic Heterojunction.

MiRNA-133a-3p Attenuates Renal Tubular Epithelial Cell Injury via Targeting MALM1 and Suppressing the Notch Signaling Pathway in Diabetic Nephropathy

MiR-205-5p-mediated MAGI1 inhibition attenuates the injury induced by diabetic nephropathy

The Expression of miR-377-3p in Patients with DKD and the Regulatory Mechanism of miR-377-3p on the Inflammatory Response of HK-2 Cells Through TGF-β

MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy*

2466 MicroRNA-451: A potential key player in the development of diabetic nephropathy in an insulin resistant mouse model